Skip to content

Generative AI Plan for Care Lab Study

Generative AI Pre-visit Lab Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07552311
Enrollment
40000
Registered
2026-04-27
Start date
2025-11-21
Completion date
2026-12-31
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Health Care

Brief summary

This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.

Interventions

OTHERFitbit Plan for Care Lab

A user informational tool using generative AI models

Plan for Care baseline model

Sponsors

Fitbit LLC
Lead SponsorINDUSTRY
Google LLC.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age of majority: are of legal adult age (18 or older in most US states; 19 or older in Nebraska \& Alabama, or 21 or older in Mississippi) 2. Resides in the United States 3. Fitbit mobile user using their Google accounts on an Android smartphone 4. Able to read, write and willing to consent in English

Exclusion criteria

1. Enrollment using a corporate google.com account 2. Have a condition or circumstance that the investigator determines as inappropriate for participation. 3. Have a chief complaint or symptoms that are potentially related to mental health disorders, sexually transmitted diseases or infections, or pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Participant Self-Reported assessmentDay 1Determine participants' self-reported assessment of the pre-visit experience, such as satisfaction on a likert scale

Countries

United States

Contacts

CONTACTBhavna Daryani, BDS
bhavnad@google.com2018859852

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026